Synthesis, structure and affinity of novel 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones for CNS central and peripheral benzodiazepine receptors
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
219 0
SM ISO690:2012
ANDRONATI, Sergei, SEMENISHYNA, Ekaterina, PAVLOVSKY, Victor, SIMONOV, Yurii A., MAKAN, Svetlana, BOIKO, Iryna, BURENKOVA, Natalya, GDANIEC, Maria, CARDINAEL, Pascal, BOUILLON, Jean-Philippe, MAZEPA, Aleksandr. Synthesis, structure and affinity of novel 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones for CNS central and peripheral benzodiazepine receptors. In: European Journal of Medicinal Chemistry, 2010, vol. 45, pp. 1346-1351. ISSN 0223-5234. DOI: https://doi.org/10.1016/j.ejmech.2009.12.027
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
European Journal of Medicinal Chemistry
Volumul 45 / 2010 / ISSN 0223-5234 /ISSNe 1768-3254

Synthesis, structure and affinity of novel 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones for CNS central and peripheral benzodiazepine receptors

DOI:https://doi.org/10.1016/j.ejmech.2009.12.027

Pag. 1346-1351

Andronati Sergei1, Semenishyna Ekaterina1, Pavlovsky Victor1, Simonov Yurii A.2, Makan Svetlana1, Boiko Iryna1, Burenkova Natalya1, Gdaniec Maria3, Cardinael Pascal4, Bouillon Jean-Philippe4, Mazepa Aleksandr1
 
1 A.V. Bogatsky Physico-Chemical Institute of the NAS of Ukraine,
2 Institute of Applied Physics, Academy of Sciences of Moldova,
3 Adam Mickiewicz University in Poznan,
4 Rouen University
 
 
Disponibil în IBN: 4 iulie 2023


Rezumat

A series of novel 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones (7-15) was synthesized and their in vitro affinity for both the central benzodiazepine receptor (CBR) and the peripheral benzodiazepine receptor (PBR) of rat brain was studied. Racemic mixture of 7-bromo-3-(2-methoxy)ethoxy-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepin-2-one (13) was separated into enantiomers 14, 15 by chiral HPLC. Absolute configuration of R-enantiomer 15 was determined by the method of X-ray diffraction analysis. The affinity of S-enantiomer 14 for CBR (I{cyrillic, ukrainian}C50 = 245 nM) is 20-fold higher than the affinity of R-enantiomer 15 (I{cyrillic, ukrainian}C50 = 4930 nM). A high selectivity for CBR versus PBR (I{cyrillic, ukrainian}C50 (PBR) > 10000 nM) was shown by all reported compounds. Compound 12 was revealed as a potent (IC50 = 9 nM) and selective CBR ligand among the synthesized 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones.

Cuvinte-cheie
3-alkoxy-1, 2-dihydro-3H-1, 4-bezodiazepin-2-ones, affinity, Central benzodiazepine receptor, enantiomer, Peripheral benzodiazepine receptor, X-ray analysis

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-184312</cfResPublId>
<cfResPublDate>2010-04-01</cfResPublDate>
<cfStartPage>1346</cfStartPage>
<cfISSN>0223-5234</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/184312</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'>Synthesis, structure and affinity of novel 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones for CNS central and peripheral benzodiazepine receptors</cfTitle>
<cfKeyw cfLangCode='EN' cfTrans='o'>3-alkoxy-1; 2-dihydro-3H-1; 4-bezodiazepin-2-ones; affinity; Central benzodiazepine receptor; enantiomer; Peripheral benzodiazepine receptor; X-ray analysis</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>A series of novel 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones (7-15) was synthesized and their in vitro affinity for both the central benzodiazepine receptor (CBR) and the peripheral benzodiazepine receptor (PBR) of rat brain was studied. Racemic mixture of 7-bromo-3-(2-methoxy)ethoxy-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepin-2-one (13) was separated into enantiomers 14, 15 by chiral HPLC. Absolute configuration of R-enantiomer 15 was determined by the method of X-ray diffraction analysis. The affinity of S-enantiomer 14 for CBR (I{cyrillic, ukrainian}C<sub>50</sub>&nbsp;= 245 nM) is 20-fold higher than the affinity of R-enantiomer 15 (I{cyrillic, ukrainian}C<sub>50</sub>&nbsp;= 4930 nM). A high selectivity for CBR versus PBR (I{cyrillic, ukrainian}C<sub>50</sub>&nbsp;(PBR) &gt; 10000 nM) was shown by all reported compounds. Compound 12 was revealed as a potent (IC<sub>50</sub>&nbsp;= 9 nM) and selective CBR ligand among the synthesized 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones.</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-13834</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-22078</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-54360</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-1070</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-78290</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-83868</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-58791</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-14399</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-109810</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-109811</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-75582</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfFedId>
<cfFedIdId>ibn-doi-184312</cfFedIdId>
<cfFedId>10.1016/j.ejmech.2009.12.027</cfFedId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFedId_Class>
<cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId>
<cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId>
</cfFedId_Class>
<cfFedId_Srv>
<cfSrvId>5123451</cfSrvId>
<cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId>
</cfFedId_Srv>
</cfFedId>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-13834</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13834-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFamilyNames>Andronati</cfFamilyNames>
<cfFirstNames>Sergei</cfFirstNames>
<cfFamilyNames>Андронати</cfFamilyNames>
<cfFirstNames>Сергей</cfFirstNames>
<cfFamilyNames>Андронаті</cfFamilyNames>
<cfFirstNames>С.</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-22078</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-22078-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFamilyNames>Semenishyna</cfFamilyNames>
<cfFirstNames>Ekaterina</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-54360</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-54360-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFamilyNames>Pavlovsky</cfFamilyNames>
<cfFirstNames>Victor</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-1070</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-1070-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFamilyNames>Simonov</cfFamilyNames>
<cfFirstNames>Yurii A.</cfFirstNames>
<cfFamilyNames>Симонов</cfFamilyNames>
<cfFirstNames>Юрий</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-78290</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-78290-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFamilyNames>Makan</cfFamilyNames>
<cfFirstNames>Svetlana</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-83868</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-83868-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFamilyNames>Boiko</cfFamilyNames>
<cfFirstNames>Iryna</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-58791</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-58791-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFamilyNames>Burenkova</cfFamilyNames>
<cfFirstNames>Natalya</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-14399</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-14399-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFamilyNames>Гданиек</cfFamilyNames>
<cfFirstNames>Мария</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-109810</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-109810-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFamilyNames>Cardinael</cfFamilyNames>
<cfFirstNames>Pascal</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-109811</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-109811-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFamilyNames>Bouillon</cfFamilyNames>
<cfFirstNames>Jean-Philippe</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-75582</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-75582-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2010-04-01T24:00:00</cfStartDate>
<cfFamilyNames>Mazepa</cfFamilyNames>
<cfFirstNames>Aleksandr</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfSrv>
<cfSrvId>5123451</cfSrvId>
<cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName>
<cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr>
<cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw>
</cfSrv>
</CERIF>